isotretinoin online
 
 
 
 
 
 

 This page is the on-line source for all XEMICS SA press information.
 For press and public relations questions or inquiries, please contact XEMICS Public Relations.

  l a t e s t   p r e s s   r e l e a s e s
June 11, 2002
Listen In With EasyBlue™
May 27, 2002
Biocontrol and XEMICS Announce the First Human Implantation of the MiniatURO™
May 6, 2002
RFast; XEMICS' Fast RF Evaluation and Development Environment
May 1, 2002
Growing demand fuels XEMICS Asia-Pacific expansion
February 11, 2002
XEMICS Unleashes its 900MHz Ultra Low-Power Transceiver !
January 28, 2002
The most cost effective wireless headset yet
January 15, 2002
Dedicated Ultra-Low Power Microcontroller for RF Communication
December 17, 2001
XEMICS And PHYTON join forces to create an In-Circuit-Emulator
December 10, 2001
IAR Systems and XEMICS close a deal on development systems for Bluetooth™ products
November 22, 2001
XEMICS Closes $6 Million Round of Financing

See all the news
 
  XEMICS announces a 10 for 1 stock split, stock options for all employees and a new shareholder structure
   
Neuchâtel, Switzerland and Mountain View, CA August 15, 2000  
   
Neuchatel, Switzerland, 15th August, 2000 - XEMICS SA, a leader in ultra low power integrated circuits, announces a 10 for 1 stock split, a 10% stock option plan for all employees and a new shareholder structure, which completes the spin-off from its founding company, CSEM SA.

CSEM SA, from which XEMICS spun off in 1997, has sold all of its remaining XEMICS shares earlier this year to Innoventure Capital, a Zurich based venture capital fund. This follows CSEM's strategy of selling its participation in companies having achieved their critical business size and in reinvesting funds in new start-up and spin-off initiatives. ''CSEM is extremely pleased with the development and progress of XEMICS over the past years as a customer-oriented global company. XEMICS successfully continues a 30 year tradition in this area of developing ultra low power integrated circuits'', says Thomas Hinderling, CSEM's CEO. '' We are looking forward to continuing our cooperation with XEMICS on advanced projects in low-power, mixed-signal semiconductor technology''.

Together with TAT Capital Partners (Switzerland) Banexi Ventures Partners (France) and Cantonal Bank of Vaud (Switzerland), venture capital funds now own approximately half of XEMICS shares. ROLEX, the Swiss watch manufacturer, and institutional investors also hold about half of XEMICS shares. The remaining shares are owned by XEMICS' senior management. ''We have now achieved an optimal shareholder structure, balancing the interests of international growth, long-term financial stability and management commitment'', says Michel Desbard, XEMICS' new Chairman of the Board.

XEMICS earlier this year approved and implemented a 10% stock option plan for all of its employees. ''Knowing that all employees will soon become shareholders has clearly sharpened the company's determination for success. It adds a new dimension by allowing all employees to actively participate in the company's development'', says Roland Heer, XEMICS' CEO. ''It will definitely help in recruiting and retaining future and current personnel, a key factor in future growth.''

XEMICS also announced today a 10 for 1 stock split to improve tradability of its shares and to achieve a share value typical for the semiconductor industry.
 

 © 2002 XEMICS All Rights Reserved
best site milf women cooney wide choice